Results 51 to 60 of about 3,019,075 (217)

Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges

International Journal of Molecular Sciences
Gliomas, particularly glioblastoma (GBM), represent the most prevalent and aggressive tumors of the central nervous system (CNS). Despite recent treatment advancements, patient survival rates remain low.
A. Seyhan
semanticscholar   +1 more source

Performance of Liquid Biopsy for Diagnosis and Surveillance of Human Papillomavirus-Associated Oropharyngeal Cancer.

JAMA Otolaryngology - Head and Neck Surgery, 2023
Importance There is growing interest in the use of circulating plasma tumor human papillomavirus (HPV) DNA for diagnosis and surveillance of patients with HPV-associated oropharyngeal squamous cell carcinoma (OPSCC).
R. Ferrandino, Sida Chen, C. Kappauf, Joshua Barlow, Brandon Gold, Michael H Berger, W. Westra, M. Teng, M. Khan, M. Posner, K. Misiukiewicz, R. Bakst, K. Sindhu, E. Genden, Raymond L. Chai, S. Roof   +15 more
semanticscholar   +1 more source

Biopsy confirmation of metastatic sites in breast cancer patients:clinical impact and future perspectives [PDF]

, 2014
Determination of hormone receptor (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor 2 status in the primary tumor is clinically relevant to define breast cancer subtypes, clinical outcome,and the choice of therapy ...
A Santinelli, AJ Montero, Alastair M Thompson, AM Thompson, Angela Esposito, Aron Goldhirsch, B Weigelt, BG Mobbs, C Liedtke, C Simmons, C Tapia, CA Gomez-Roca, Carmen Criscitiello, CH Lu, D Gancberg, DS Seah, E Amir, E Amir, E Brogi, EA Mittendorf, EA Perez, EA Perez, EE Lower, EE Lower, F Andre, F André, F Liebens, Fabrice André, Franco Orsi, G Aurilio, G Bogina, G Curigliano, G Viale, Giuseppe Curigliano, HJ Chang, Ida Minchella, J Carlsson, JM Wu, L Ding, L Pusztai, LD Hoefnagel, LM Bender, LS Lindstrom, LS Steelman, Luca Fumagalli, Lucia Gelao, M Scaltriti, Marzia Locatelli, Michele De Laurentiis, MJ Higgins, N Niikura, PJ Stephens, PK Idirisinghe, R Fisher, R Simon, RJ Broom, RJ Leary, S Gupta, S Vignot, SJ Aitken, SM Edgerton, SP Shah, ST Wong, T Forshew, U Wilking, V Guarneri, W Onstenk, Y Gong, Y Nagata, YM Lo   +69 more
core   +4 more sources

Emerging role of exosomes as a liquid biopsy tool for diagnosis, prognosis & monitoring treatment response of communicable & non-communicable diseases

The Indian journal of medical research
From an initial thought of being used as a cellular garbage bin to a promising target for liquid biopsies, the role of exosomes has drastically evolved in just a few years of their discovery in 1983.
R. Yadav, Ajay Vir Singh, Shweta Kushwaha, Devendra Singh Chauhan   +3 more
semanticscholar   +1 more source

Liquid biopsy: from concept to clinical application

Scientific Reports, 2023
The diagnosis and treatment of cancer presents a physical and mental burden to the patient, often involving diagnostic biopsies and surgeries or chemotherapeutic approaches with severe side-effects.
C. Alix-Panabières, Dario Marchetti, Julie E. Lang   +2 more
semanticscholar   +1 more source

Evaluation of the diagnostic value of a Modified Liquid-Based Cytology using OralCDx Brush in early detection of oral potentially malignant lesions and oral cancer [PDF]

, 2010
Objectives: To determine diagnostic value of modified Liquid Based Brush Biopsy technique. Study design: 26 oral premalignant and malignant lesions in 25 patients (12 females; 54.23±19.77 years and 13 males; 53.77±15.43 years) underwent Modified ...
Delavarian, Zarha, Ghafoorian Maddah, Rasoul, Mohtasham, Nooshin, Mosannen-Mozaffari, Pegah, Pakfetrat, Atessa, Shakeri, Mohammad-Taghi   +5 more
core   +1 more source

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment

MedComm
Currently, tumor treatment modalities such as immunotherapy and targeted therapy have more stringent requirements for obtaining tumor growth information and require more accurate and easy‐to‐operate tumor information detection methods.
Hao Wang, Yi Zhang, Hao Zhang, Hui Cao, Jinning Mao, Xinxin Chen, Liangchi Wang, Nan Zhang, Peng Luo, Ji Xue, Xiaoya Qi, Xiancheng Dong, Guodong Liu, Q. Cheng   +13 more
semanticscholar   +1 more source

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

Molecular Cancer, 2022
Over the past decade, invasive techniques for diagnosing and monitoring cancers are slowly being replaced by non-invasive methods such as liquid biopsy.
S. N. Lone, Sabah Nisar, Tariq Ahmad Masoodi, Mayank Singh, Arshi Rizwan, Sheema Hashem, W. El-Rifai, D. Bedognetti, S. Batra, Mohammad Haris, A. Bhat, M. Macha   +11 more
semanticscholar   +1 more source

Genomic biomarkers in prostate cancer. [PDF]

, 2018
Prostate cancer is the most common non-cutaneous cancer among men in the United States. In the last decade there has been a rapid expansion in the field of biomarker assays for diagnosis, prognosis, and treatment prediction in prostate cancer.
Cooperberg, Matthew R, Feng, Felix Y, Kornberg, Zachary, Spratt, Daniel E   +3 more
core  

A lab-on-a-disc platform enables serial monitoring of individual CTCs associated with tumor progression during EGFR-targeted therapy for patients with NSCLC [PDF]

, 2020
Rationale: Unlike traditional biopsy, liquid biopsy, which is a largely non-invasive diagnostic and monitoring tool, can be performed more frequently to better track tumors and mutations over time and to validate the efficiency of a cancer treatment ...
Cho, Yoon-Kyoung, Jeong, Hyoung-oh, Kim, Gwang Ha, Kim, Mi-Hyun, Lee, Kyusang, Lee, Semin, Lim, Minji, Lowe, Alarice C., Park, Hee Chul, Park, Juhee   +9 more
core   +1 more source